Betina Durovni, Valeria Saraceni, Lawrence H. Moulton, Antonio G. Pacheco, Solange C. Cavalcante, Bonnie S. King, Silvia Cohn, Anne Efron, Richard E. Chaisson, Jonathan E. Golub: Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial. In: The Lancet Infectious Diseases. 2013, S. , doi:10.1016/S1473-3099(13)70187-7.
C. E. Cade, A. C. Dlouhy u. a.: Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities. In: Protein science : a publication of the Protein Society Band 19, Nummer 3, März 2010, S. 458–474. doi:10.1002/pro.324. PMID 20054829. PMC 286627 (freier Volltext).
merckmillipore.com
Datenblatt Isoniazid bei Merck, abgerufen am 19. Januar 2011.
nih.gov
ncbi.nlm.nih.gov
D. A. Rozwarski, G. A. Grant u. a.: Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. In: Science Band 279, Nummer 5347, Januar 1998, S. 98–102. PMID 9417034.
C. E. Cade, A. C. Dlouhy u. a.: Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities. In: Protein science : a publication of the Protein Society Band 19, Nummer 3, März 2010, S. 458–474. doi:10.1002/pro.324. PMID 20054829. PMC 286627 (freier Volltext).